| Systemic Lupus Erythematosus |
1 |
1 |
| Lupus |
0 |
0.78 |
| Lupus Nephritis |
0 |
0.99 |
| Nephritis |
0 |
0.98 |
| Oklahoma |
0 |
0.24 |
| Biologic Therapy |
0 |
0.22 |
| Glucocorticoid |
0 |
0.18 |
| Organ Transplantation |
0 |
0.17 |
| Pregnancy |
0 |
0.14 |
| Congenital Anomaly |
0 |
0.13 |
| Contraception |
0 |
0.13 |
| Sterilization, Birth Control |
0 |
0.13 |
| Birth |
0 |
0.12 |
| California |
0 |
0.12 |
| Patient Safety |
0 |
0.12 |
| Transplantation |
0 |
0.12 |
| Intensive Care Unit |
0 |
0.1 |
| Pneumonia |
0 |
0.1 |
| Revenue and Practice Management |
0 |
0.1 |
| Elevated Liver Function Test |
0 |
0.09 |
| Genomic Medicine |
0 |
0.09 |
| Herpes Zoster |
0 |
0.09 |
| Influenza |
0 |
0.09 |
| Adverse Effects |
0 |
0.06 |
| Biomarker |
0 |
0.06 |
| Brain |
0 |
0.06 |
| Cancer |
0 |
0.06 |
| Clinical Research |
0 |
0.06 |
| Diarrhea |
0 |
0.06 |
| Grant |
0 |
0.06 |
| Healthcare and Medical Technology |
0 |
0.06 |
| Heart |
0 |
0.06 |
| Hospital |
0 |
0.06 |
| Immunosuppressive Therapy |
0 |
0.06 |
| Insurance |
0 |
0.06 |
| Kidney |
0 |
0.06 |
| Liver |
0 |
0.06 |
| Lung |
0 |
0.06 |
| Lymphoma |
0 |
0.06 |
| Massachusetts |
0 |
0.06 |
| Nausea |
0 |
0.06 |
| Off-Label Use |
0 |
0.06 |
| Precision Medicine |
0 |
0.06 |
| Spontaneous Abortion |
0 |
0.06 |
| Steroids |
0 |
0.06 |
| Vaccines |
0 |
0.06 |
| Vasculitis |
0 |
0.06 |